APA
Martínez-Sánchez P., Montejano L., Sarasquete M. E., García-Sanz R., Fernández-Redondo E., Ayala R., Montalbán M. A., Martínez R., García Laraña J., Alegre A., Hernández B., Lahuerta J. J. & Martínez-López J. (20081204). Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response. : British journal of haematology.
Chicago
Martínez-Sánchez Pilar, Montejano Laura, Sarasquete Maria Eugenia, García-Sanz Ramón, Fernández-Redondo Elena, Ayala Rosa, Montalbán María Angeles, Martínez Rafael, García Laraña José, Alegre Adrian, Hernández Belen, Lahuerta Juan José and Martínez-López Joaquín. 20081204. Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response. : British journal of haematology.
Harvard
Martínez-Sánchez P., Montejano L., Sarasquete M. E., García-Sanz R., Fernández-Redondo E., Ayala R., Montalbán M. A., Martínez R., García Laraña J., Alegre A., Hernández B., Lahuerta J. J. and Martínez-López J. (20081204). Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response. : British journal of haematology.
MLA
Martínez-Sánchez Pilar, Montejano Laura, Sarasquete Maria Eugenia, García-Sanz Ramón, Fernández-Redondo Elena, Ayala Rosa, Montalbán María Angeles, Martínez Rafael, García Laraña José, Alegre Adrian, Hernández Belen, Lahuerta Juan José and Martínez-López Joaquín. Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response. : British journal of haematology. 20081204.